These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35535333)

  • 1. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
    Yu H; Bai X; Zheng W
    Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
    Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients.
    Gao X; Wang WX; Zhang XL
    Cancer Med; 2023 Jan; 12(1):808-823. PubMed ID: 35651286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
    Xing M; Li J
    BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
    Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
    BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 14. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pyroptosis subtypes and prognosis model of hepatocellular carcinoma based on pyroptosis-related genes.
    Xie H; Huang G; Mai H; Chen J; Na R; Jiang DK
    Cancer Med; 2024 Aug; 13(15):e70081. PubMed ID: 39126216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing.
    He J; Ran J; Li J; Chen D
    Transl Cancer Res; 2022 Jun; 11(6):1510-1522. PubMed ID: 35836524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
    Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
    Front Oncol; 2022; 12():986827. PubMed ID: 36267972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
    Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
    Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.